SMA
ENZ

Sage Mountain Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Sage Mountain Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,195
Closed -$18K – 453
2024
Q1 		$18K Hold
14,195
– – ﹤0.01% 377
2023
Q4 		$19.7K Sell
14,195
-9,167
-39% -$12.2K ﹤0.01% 324
2023
Q3 		$32.7K Hold
23,362
– – ﹤0.01% 314
2023
Q2 		$43K Buy
+23,362
New +$54.1K 0.01% 304

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Sage Mountain Advisors's ENZ Position: Q2 2024 in Review

Sage Mountain Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2024, closing a stake of 14,195 shares — an estimated $18K sold.

Sage Mountain Advisors first reported a position in ENZ in Q2 2023 and held it in 4 quarters. The position peaked at $43K in Q2 2023. 39 funds tracked by Wall St. Rank hold ENZ as of Q2 2024.

  • Sage Mountain Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2024 after selling out during the quarter.
  • Sage Mountain Advisors sold 14,195 Enzo Biochem, Inc. shares in Q2 2024, an estimated $18K.
  • Sage Mountain Advisors first reported a position in Enzo Biochem, Inc. in Q2 2023 and held it in 4 quarters.
  • Sage Mountain Advisors's Enzo Biochem, Inc. position peaked at $43K in Q2 2023.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2024.

Based on Sage Mountain Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.